Irritation/Irritant

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Irritation/Irritant trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07517874

Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volun…

The objective of this study is to investigate the irritation and sensitization potential of 1 topically applied test article containing Mitopure in a shared pan…

United Kingdom100 participantsStarted 2026-04-20

Treatment: Mitopure Topical Formula 11

All recent trials (25 shown)

CompletedNot Applicable

NCT07100912

Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volun…

The objective of this study is to investigate the irritation and sensitization potential of 6 different topically applied test articles containing Mitopure in a…

United Kingdom113 participantsStarted 2025-08-18

Treatment: Mitopure Topical Formula 5, Mitopure Topical Formula 6

CompletedNot Applicable

NCT06884215

Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunte…

The objective of this study is to investigate the irritation and sensitization potential of multiple topically applied test articles (containing different conce…

United Kingdom112 participantsStarted 2025-03-17

Treatment: Mitopure Topical Formula 3, Mitopure Topical Formula 4

Irritation/Irritant

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volun…

All recent trials (25 shown)

Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volun…

Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunte…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volun…

All recent trials (25 shown)

Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volun…

Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunte…

Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Photosensitization…

A Study to Learn About Whether BAYH006689 Causes Skin Irritation When Applied as a Topical Gel in Healthy Participants

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design

4-Day Primary Irritation Patch Test of MIS Solution

The Effects of Repeated Exposure to Antiseptics During COVID-19 Pandemic on Skin Parameters

Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects

A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants

Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis

Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunt…

Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System

Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion

50 Human Subject Repeat Insult Patch Test

A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% Ointment

Dermal Cumulative Irritant Patch Study

Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery

BM Collection From NICU Infants for Composition

Preliminary Evaluation of CASTLE Barrier Prototype UK

21 Day Cumulative Skin Irritation of RUT058-60